Article
Author(s):
Make the Pain Stop: New Shared Platform Eases Investigators’ Burden
TransCelerate BioPharma Inc. CEO Dr. Dalvir Gill shares results of their recent collaboration with the Society for Clinical Research Sites: The Shared Investigator Platform designed to reduce administrative burden by enabling investigative sites to interact with multiple clinical trial sponsors through a single point of access.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
2 Commerce Drive
Cranbury, NJ 08512